Biostax Corp (BTAX)

[locicat1]

The inclusion of IMUN in the Research and Markets report is a least crazy. As stated earlier, it would be extremely interesting and very important to know the information that the report producing company has that would have led to their decision to add IMUN as one of the profiled companies covering this significant area of research and therapeutic potential. Hopefully it is more than in the five paragraphs of the April 21, 2016 press release related to the announcement of a Letter of Intent to acquire the purported Chinese CAR-T Technology and Clinical Data.